Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anavex Life Sciences

9.36
+0.05000.54%
Post-market: 9.540.1800+1.92%17:33 EDT
Volume:526.78K
Turnover:4.96M
Market Cap:796.20M
PE:-16.94
High:9.59
Open:9.44
Low:9.23
Close:9.31
Loading ...

We're Not Worried About Anavex Life Sciences' (NASDAQ:AVXL) Cash Burn

Simply Wall St.
·
25 Dec 2024

Anavex Life Sciences Faces Manufacturing Challenges Impacting Product Launch and Financial Stability

TIPRANKS
·
25 Dec 2024

Stock Track | Anavex Life Sciences Soars 8.32% on Positive Alzheimer's Drug Updates and Strong Financials

Stock Track
·
24 Dec 2024

Stock Track | Anavex Life Sciences Soars 7.33% Pre-market on Positive Alzheimer's Drug Updates and Strong Financials

Stock Track
·
24 Dec 2024

Anavex Life Sciences Corp (AVXL) Q4 2024 Earnings Call Highlights: Strong Cash Position and ...

GuruFocus.com
·
24 Dec 2024

Q4 2024 Anavex Life Sciences Corp Earnings Call

Thomson Reuters StreetEvents
·
24 Dec 2024

Anavex Life Sciences Up Over 29%, on Pace for Largest Percent Increase Since December 2022 -- Data Talk

Dow Jones
·
24 Dec 2024

Stock Track | Anavex Life Sciences Soars 15.87% as EMA Accepts Filing for Potential Alzheimer's Treatment Blarcamesine

Stock Track
·
23 Dec 2024

Anavex Says it Gets EMA Filing Acceptance for Blarcamesine to Treat Alzheimer's Disease

MT Newswires Live
·
23 Dec 2024

Anavex Life Sciences: Fiscal Q4 Earnings Snapshot

Associated Press Finance
·
23 Dec 2024

Anavex Life Sciences' Loss Widens on Higher Costs

Dow Jones
·
23 Dec 2024

Anavex Life Sciences Q4 2024 GAAP EPS $(0.14) Beats $(0.16) Estimate; Cash Of $132.2M

Benzinga
·
23 Dec 2024

Anavex Life Sciences Reports Fiscal 2024 Fourth Quarter Financial Results and Provides Business Update

THOMSON REUTERS
·
23 Dec 2024

Anavex Life Sciences Corp Qtrly Loss per Share $0.14

THOMSON REUTERS
·
23 Dec 2024

Stock Track | Anavex Life Sciences Soars 9.85% in Pre-Market on EMA Acceptance of Alzheimer's Drug Filing

Stock Track
·
23 Dec 2024

Anavex receives EMA filing acceptance for treatment of Alzheimer’s disease

TIPRANKS
·
23 Dec 2024

Options Volatility and Implied Earnings Moves This Week, December 23 – December 26, 2024

TIPRANKS
·
23 Dec 2024

Blarcamesine Receives Ema Filing Acceptance for Treatment of Alzheimer’s Disease

THOMSON REUTERS
·
23 Dec 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
23 Dec 2024

Qualcomm, Limoneira And 3 Stocks To Watch Heading Into Monday

Benzinga
·
23 Dec 2024